Tramadol added to bupivacaine does not prolong analgesia of continuous psoas compartment block.
The primary aim of our study was to evaluate the quality and duration of analgesia when tramadol was added to 0.25% bupivacaine for continuous psoas compartment block (CPCB) using visual analog pain scores. Thirty patients were prospectively randomized into two equal groups (n = 15). Visual analog scale pain score was not significantly different between the groups during the 48-hour follow-up period. Rescue analgesic consumption, nausea and vomiting, and the satisfaction scores were comparable between the groups (P > 0.05). Success with catheter placement adjacent to the lumbar plexus was 100%, and none of the patients developed any catheter-related complications. In conclusion, tramadol does not provide a clinically significant analgesic action as an adjunct to 0.25% bupivacaine for CPCB.
Kumar
Mukesh
M
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Batra
Yatindra Kumar
YK
Panda
Nidhi Bidyut
NB
Rajeev
Subramanyam
S
Nagi
Onkar Nath
ON
D000700:Analgesics; D000779:Anesthetics, Local; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D002045:Bupivacaine; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009407:Nerve Block / Q000379:methods*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000188:drug therapy / Q000209:etiology; D016658:Psoas Muscles; D014147:Tramadol
D000700:Analgesics; D000779:Anesthetics, Local; D014147:Tramadol; D002045:Bupivacaine